Maria Rosa Cappelletti

1.7k total citations
32 papers, 635 citations indexed

About

Maria Rosa Cappelletti is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Maria Rosa Cappelletti has authored 32 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Maria Rosa Cappelletti's work include Cancer Genomics and Diagnostics (7 papers), Prostate Cancer Treatment and Research (5 papers) and HER2/EGFR in Cancer Research (4 papers). Maria Rosa Cappelletti is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Prostate Cancer Treatment and Research (5 papers) and HER2/EGFR in Cancer Research (4 papers). Maria Rosa Cappelletti collaborates with scholars based in Italy, United States and Australia. Maria Rosa Cappelletti's co-authors include Daniele Generali, Laura Zanotti, Giandomenico Roviello, Alberto Bottini, Andrea Ravelli, Stephen B. Fox, Giuseppina Ferrero, Fabrizio Zanconati, Alberto Bonetta and Daniele Cretella and has published in prestigious journals such as Cancer Research, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Maria Rosa Cappelletti

29 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Rosa Cappelletti Italy	13	312	251	239	213	64	32	635
Tommasina Biscotti Italy	13	430 1.4×	233 0.9×	208 0.9×	182 0.9×	98 1.5×	21	690
Olga Martínez‐Sáez Spain	11	458 1.5×	343 1.4×	298 1.2×	293 1.4×	54 0.8×	60	832
Francesca Romana Tofanetti Italy	14	394 1.3×	386 1.5×	214 0.9×	375 1.8×	66 1.0×	32	781
Evangelos Bournakis Greece	15	267 0.9×	160 0.6×	153 0.6×	272 1.3×	66 1.0×	35	621
Giacomo Pelizzari Italy	15	394 1.3×	271 1.1×	158 0.7×	146 0.7×	39 0.6×	50	623
Federica Martorana Italy	14	375 1.2×	250 1.0×	226 0.9×	326 1.5×	93 1.5×	55	869
Jeanne Fourie Zirkelbach United States	11	267 0.9×	218 0.9×	104 0.4×	122 0.6×	46 0.7×	14	557
V. Papadimitrakopoulou United States	13	313 1.0×	304 1.2×	110 0.5×	223 1.0×	41 0.6×	41	606
Myriam Kossaï France	10	279 0.9×	173 0.7×	258 1.1×	277 1.3×	151 2.4×	36	768
R. Molife United Kingdom	11	291 0.9×	277 1.1×	162 0.7×	300 1.4×	34 0.5×	24	694

Countries citing papers authored by Maria Rosa Cappelletti

Since Specialization

Citations

This map shows the geographic impact of Maria Rosa Cappelletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Rosa Cappelletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Rosa Cappelletti more than expected).

Fields of papers citing papers by Maria Rosa Cappelletti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Rosa Cappelletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Rosa Cappelletti. The network helps show where Maria Rosa Cappelletti may publish in the future.

Co-authorship network of co-authors of Maria Rosa Cappelletti

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Rosa Cappelletti. A scholar is included among the top collaborators of Maria Rosa Cappelletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Rosa Cappelletti. Maria Rosa Cappelletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schettini, Francesco, Alessandra Fontana, Carla Strina, et al.. (2023). Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study. European Journal of Cancer. 191. 112948–112948. 9 indexed citations

Schettini, Francesco, Maria Valeria De Bonis, Carla Strina, et al.. (2023). Computational reactive–diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib. Scientific Reports. 13(1). 11951–11951.

Bortul, Marina, Fabiola Giudici, Daniele Generali, et al.. (2023). A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection. International Journal of Molecular Sciences. 24(10). 8520–8520. 5 indexed citations

Alborelli, Ilaria, Daniele Generali, Philip Jermann, et al.. (2019). Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study. Cell Death and Disease. 10(7). 534–534. 100 indexed citations

Triulzi, Tiziana, Viola Regondi, Loris De Cecco, et al.. (2018). Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit. British Journal of Cancer. 119(12). 1487–1494. 37 indexed citations

Roviello, Giandomenico, Silvia Paola Corona, Alberto Bonetta, Maria Rosa Cappelletti, & Daniele Generali. (2017). Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer. OncoTargets and Therapy. Volume 10. 3811–3815. 7 indexed citations

Corona, Silvia Paola, Andrea Ravelli, Daniele Cretella, et al.. (2017). CDK4/6 inhibitors in HER2-positive breast cancer. Critical Reviews in Oncology/Hematology. 112. 208–214. 37 indexed citations

Bonetta, Alberto, Giandomenico Roviello, Daniele Generali, et al.. (2017). Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma. Research and Reports in Urology. Volume 9. 65–69. 5 indexed citations

Milani, Manuela, Sergio Venturini, Simone Bonardi, et al.. (2017). Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer. Oncotarget. 8(45). 78870–78881. 10 indexed citations

10.

Ravelli, Andrea, Giandomenico Roviello, Daniele Cretella, et al.. (2017). Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility. Tumor Biology. 39(4). 3726131102–3726131102. 68 indexed citations

11.

Guffanti, Federica, Maddalena Fratelli, Monica Ganzinelli, et al.. (2017). Abstract 508: DNA repair status in a patient derived ovarian cancer xenobank. Cancer Research. 77(13_Supplement). 508–508. 1 indexed citations

12.

Roviello, Giandomenico, et al.. (2016). Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 15(3). 371–375. 3 indexed citations

13.

Roviello, Giandomenico, Manuela Milani, Maria Rosa Cappelletti, et al.. (2016). A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers. Clinical Breast Cancer. 16(3). e57–e59. 4 indexed citations

14.

Roviello, Giandomenico, Sandra Sigala, Shahneen Sandhu, et al.. (2016). Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials. European Journal of Cancer. 61. 111–121. 46 indexed citations

15.

Roviello, Giandomenico, Andrea Ravelli, Anna Ida Fiaschi, et al.. (2016). Apatinib for the treatment of gastric cancer. Expert Review of Gastroenterology & Hepatology. 10(8). 1–6. 64 indexed citations

16.

Roviello, Giandomenico, et al.. (2016). No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials. Clinical Lung Cancer. 17(5). 334–340. 14 indexed citations

17.

Cappelletti, Maria Rosa, Letizia Gnetti, Daniele Santini, et al.. (2015). Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?. Oncoscience. 2(6). 567–569. 2 indexed citations

18.

Ravelli, Andrea, James M. Reuben, Francesco Lanza, et al.. (2015). Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity. Expert Review of Anticancer Therapy. 15(6). 689–702. 11 indexed citations

19.

Ravelli, Andrea, James M. Reuben, Francesco Lanza, et al.. (2015). Breast cancer circulating biomarkers: advantages, drawbacks, and new insights. Tumor Biology. 36(9). 6653–6665. 35 indexed citations

20.

Zanotti, Laura, Alberto Bottini, Camillo Rossi, Daniele Generali, & Maria Rosa Cappelletti. (2014). Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use. Tumor Biology. 35(9). 8461–8470. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact